Diabetes and the Risk of Developing Parkinson’s Disease in Denmark
Open Access
- 20 April 2011
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 34 (5), 1102-1108
- https://doi.org/10.2337/dc10-1333
Abstract
OBJECTIVE: Insulin contributes to normal brain function. Previous studies have suggested associations between midlife diabetes and neurodegenerative diseases, including Parkinson’s disease. Using Danish population registers, we investigated whether a history of diabetes or the use of antidiabetes drugs was associated with Parkinson’s disease. RESEARCH DESIGN AND METHODS: From the nationwide Danish Hospital Register hospital records, we identified 1,931 patients with a first-time diagnosis of Parkinson’s disease between 2001 and 2006. We randomly selected 9,651 population control subjects from the Central Population Registry and density matched them by birth year and sex. Pharmacy records comprising all antidiabetes and anti-Parkinson drug prescriptions in Denmark were available. Odds ratios (ORs) were estimated by logistic regression models. RESULTS: Having diabetes, as defined by one or more hospitalizations and/or outpatient visits for the condition, was associated with a 36% increased risk of developing Parkinson’s disease (OR 1.36 [95% CI 1.08–1.71]). Similarly, diabetes defined by the use of any antidiabetes medications was associated with a 35% increased Parkinson’s disease risk (1.35 [1.10–1.65]). When diabetes was defined as the use of oral antidiabetes medications, effect estimates were stronger in women (2.92 [1.34–6.36]), whereas when diabetes was defined as any antidiabetes drug prescription, patients with early-onset Parkinson’s disease were at highest risk (i.e., Parkinson’s disease diagnosed before the age of 60 years; 3.07 [1.65–5.70]). CONCLUSIONS: We found that a diagnosis of, or treatment received for, diabetes was significantly associated with an increased risk of developing Parkinson’s disease, especially younger-onset Parkinson’s disease. Our results suggest a common pathophysiologic pathway between the two diseases. Future studies should take age at Parkinson’s disease onset into account.Keywords
This publication has 26 references indexed in Scilit:
- Case–control study of risk of Parkinson's disease in relation to hypertension, hypercholesterolemia, and diabetes in JapanJournal of the Neurological Sciences, 2010
- L‐type calcium channel blockers and Parkinson disease in DenmarkAnnals of Neurology, 2010
- Autoimmune disease and risk for Parkinson diseaseNeurology, 2009
- Diabetes mellitus and drug-induced parkinsonism: A case–control studyJournal of the Neurological Sciences, 2009
- Prospective Cohort Study of Type 2 Diabetes and the Risk of Parkinson's DiseaseDiabetes Care, 2008
- Diabetes in Patients With Idiopathic Parkinson's DiseaseDiabetes Care, 2008
- Intensive Glycemic Control and Macrovascular Disease in Type 2 Diabetes – A Report on the 44th Annual EASD Meeting, Rome, Italy, September 2008The Review of Diabetic Studies, 2008
- Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson diseaseNeurology, 2007
- Reduced Risk Factors for Vascular Disorders in Parkinson Disease PatientsStroke, 2006
- Morbidity during hospitalization: Can we predict it?Journal of Chronic Diseases, 1987